Vimarsana
Biggest News Aggregation in the World

Molecular Designs News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Molecular Designs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Molecular Designs Today - Breaking & Trending Today

Molecular Designs releases their new Candida auris PCR Simplicity Panel™ - Vimarsana News

Molecular Designs releases their new Candida auris PCR Simplicity Panel™

BIRMINGHAM, Ala., Nov. 9, 2023 /PRNewswire/ — Molecular Designs, a leading provider of molecular infectious disease assays, has released its latest product, the Candida auris Simplicity Panel™. The drive to produce this real-time PCR test comes from recognizing the emerging threat of the C. auris pathogen in healthcare settings worldwide. It aims to improve the workflow for […]

Molecular Designs Receives ISO 13485:2016 Certification - Vimarsana News

Molecular Designs Receives ISO 13485:2016 Certification

/PRNewswire/ -- Molecular Designs, LLC, a developer and manufacturer of molecular multiplex pathogen assays, announced the successful completion of a recent...

Leader in Breast Cancer First-in-Class Drug Development, Martin S. Olivo, MD, MSc, joins Phoenix Molecular Designs Advisory Board - Vimarsana News

Leader in Breast Cancer First-in-Class Drug Development, Martin S. Olivo, MD, MSc, joins Phoenix Molecular Designs Advisory Board

/PRNewswire/ - Phoenix Molecular Designs (PhoenixMD), a clinical-stage biopharmaceutical company dedicated to developing precise cancer therapeutics, today...

Day Zero Diagnostics Welcomes Molecular Diagnostics Experts to its Advisory Board - Vimarsana News

Day Zero Diagnostics Welcomes Molecular Diagnostics Experts to its Advisory Board

/PRNewswire/ -- Day Zero Diagnostics Inc., an infectious disease diagnostics company utilizing genome sequencing and machine learning to combat the rise of...

Phoenix Molecular Designs Successfully Completes Patient Enrollment in Phase 1/1b Clinical Trial of PMD-026 - Vimarsana News

Phoenix Molecular Designs Successfully Completes Patient Enrollment in Phase 1/1b Clinical Trial of PMD-026

SAN DIEGO and VANCOUVER, BC, Feb. 9, 2022 /PRNewswire/ - Phoenix Molecular Designs (PhoenixMD), a clinical stage biopharmaceutical company dedicat...